Von Gahlen, founded in 1973, is a leading manufacturer of lead shielding products tailored for the nuclear medicine industry. Based in The Netherlands, this company specializes in creating both standard and customized hot cells, radiation-shielded radiopharmaceutical packaging, and precise lead components that are crucial for the industry's safety needs.
The company’s slogan, "Shielding solutions for nuclear medicine and radiopharmacy, radiopharmaceutical packaging and lead precision," underscores its commitment to delivering reliable and innovative solutions. Von Gahlen prides itself on its professional expertise and extensive experience, engaging in close cooperation with a global clientele. With a workforce of approximately 120 employees, the company conducts design, production, and assembly operations at its head office in Zevenaar.
Despite its extensive operational history and international client base, the company has not publicly disclosed recent investment activities or investor details. This positions Von Gahlen as a stable, mature player in the health care, logistics, manufacturing, and pharmaceutical industries, potentially appealing to investors interested in companies with durable market positions and established industry relevance.